Order Article Reprints

Wang C-H, Lin C-Y, Chen J-S, Ho C-L, Rau K-M, Tsai J-T, Chang C-S, Yeh S-P, Cheng C-F, Lai Y-L. Karnofsky Performance Status as A Predictive Factor for Cancer-Related Fatigue Treatment with Astragalus Polysaccharides (PG2) Injection—A Double Blind, Multi-Center, Randomized Phase IV Study. Cancers. 2019; 11(2):128. https://doi.org/10.3390/cancers11020128

Wang, Cheng-Hsu, Cheng-Yao Lin, Jen-Shi Chen, Ching-Liang Ho, Kun-Ming Rau, Jo-Ting Tsai, Cheng-Shyong Chang, Su-Peng Yeh, Chieh-Fang Cheng, and Yuen-Liang Lai. 2019. "Karnofsky Performance Status as A Predictive Factor for Cancer-Related Fatigue Treatment with Astragalus Polysaccharides (PG2) Injection—A Double Blind, Multi-Center, Randomized Phase IV Study" Cancers 11, no. 2: 128. https://doi.org/10.3390/cancers11020128

Wang, C.-H., Lin, C.-Y., Chen, J.-S., Ho, C.-L., Rau, K.-M., Tsai, J.-T., Chang, C.-S., Yeh, S.-P., Cheng, C.-F., & Lai, Y.-L. (2019). Karnofsky Performance Status as A Predictive Factor for Cancer-Related Fatigue Treatment with Astragalus Polysaccharides (PG2) Injection—A Double Blind, Multi-Center, Randomized Phase IV Study. Cancers, 11(2), 128. https://doi.org/10.3390/cancers11020128